Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo

Restoration of Mannose-Binding Lectin Complement Activity Is Associated With Improved Outcome in Patients With Advanced Pancreatic Cancer Treated With Gemcitabine and Intravenous ω-3 Fish Oil

(2013) Ali Arshad et al.   JOURNAL OF PARENTERAL AND ENTERAL NUTRITION

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer

(2013) Aurélie Courtin et al.   PLoS One

CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer

(2013) A. Neesse et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phosphatidylcholine and the CDP–choline cycle

(2012) Paolo Fagone et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells

(2012) Y Lin et al.   BRITISH JOURNAL OF CANCER

Current concepts and novel targets in advanced pancreatic cancer

(2012) Patrick Michl et al.   GUT

Reduction in circulating pro‐angiogenic and pro‐inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega‐3 fish oil

(2012) Ali Arshad et al.   HPB

nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer

(2012) Kristopher K. Frese et al.   Cancer Discovery

Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients

(2011) C. Tibaldi et al.   ANNALS OF ONCOLOGY

A novel method for quantification of gemcitabine and its metabolites 2′,2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with 19F NMR spectroscopy

(2011) Tashinga E. Bapiro et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Delineation of the Molecular Mechanisms of Nucleoside Recognition by Cytidine Deaminase through Virtual Screening

(2011) Stefano Costanzi et al.   ChemMedChem

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of hydrophilic and lipophilic choline compounds in radioresistant and radiosensitive glioblastoma cell lines by HILIC-ESI-MS/MS

(2010) D. Desoubzdanne et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Discriminating and Imaging Different Phosphatidylcholine Species within Phase-Separated Model Membranes by Principal Component Analysis of TOF-Secondary Ion Mass Spectrometry Images

(2010) Bita Vaezian et al.   ANALYTICAL CHEMISTRY

Guidelines for the welfare and use of animals in cancer research

(2010) P Workman et al.   BRITISH JOURNAL OF CANCER

Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

(2009) K. P. Olive et al.   SCIENCE

Characterization of polar membrane lipids of the extremely halophilic bacterium Salinibacter ruber and possible role of cardiolipin

(2008) Veronica M.T. Lattanzio et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Modulation of Gemcitabine (2',2'-Difluoro-2'-Deoxycytidine) Pharmacokinetics, Metabolism, and Bioavailability in Mice by 3,4,5,6-Tetrahydrouridine

(2008) J. H. Beumer et al.   CLINICAL CANCER RESEARCH

Adrenocortical carcinoma survival rates correlated to genomic copy number variants

(2008) E. A. Stephan et al.   MOLECULAR CANCER THERAPEUTICS